BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26941577)

  • 61. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
    Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
    PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.
    Wheeler MC; Gekakis N
    J Lipid Res; 2014 Aug; 55(8):1702-10. PubMed ID: 24927728
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Palmitate induces insulin resistance without significant intracellular triglyceride accumulation in HepG2 cells.
    Lee JY; Cho HK; Kwon YH
    Metabolism; 2010 Jul; 59(7):927-34. PubMed ID: 20006364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis through Activation of the PPARα/PGC1α Signaling Pathway.
    Tong Y; Zhu W; Wen T; Mukhamejanova Z; Xu F; Xiang Q; Pang J
    J Nat Prod; 2022 Jul; 85(7):1738-1750. PubMed ID: 35749236
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [FGF21 inhibits lipid accumulation and inflammation induced by palmitate in human hepatocytes via SIRT1 pathway].
    Nan Y; Xiang L; Zhang W; Guo Y; Cao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):606-612. PubMed ID: 31537245
    [TBL] [Abstract][Full Text] [Related]  

  • 67. JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
    Takahashi K; Yamaguchi S; Shimoyama T; Seki H; Miyokawa K; Katsuta H; Tanaka T; Yoshimoto K; Ohno H; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E898-909. PubMed ID: 18303122
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species.
    Wang C; Zeng W; Wang L; Xiong X; Chen S; Huang Q; Zeng G; Huang Q
    Drug Dev Res; 2024 Jun; 85(4):e22213. PubMed ID: 38798186
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
    Liu J; Li D; Dun Y; Li H; Ripley-Gonzalez JW; Zhang J; Qiu L; You B; Liu S
    Life Sci; 2022 Nov; 308():120949. PubMed ID: 36096243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
    Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Millet Bran Protein Hydrolysate Displays the Anti-non-alcoholic Fatty Liver Disease Effect via Activating Peroxisome Proliferator-Activated Receptor γ to Restrain Fatty Acid Uptake.
    Shan S; Zhou J; Yin R; Zhang L; Shi J; Qiao Q; Li Z
    J Agric Food Chem; 2023 Jan; 71(3):1628-1642. PubMed ID: 36638159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
    Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
    Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway.
    Wang Q; Li C; Zhang Q; Wang Y; Shi T; Lu L; Zhang Y; Wang Y; Wang W
    BMC Complement Altern Med; 2016 Dec; 16(1):514. PubMed ID: 27955667
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Nogo-B as a new molecular target of peroxisome proliferator-activated receptor gamma.
    Yu M; Zhang S; Guo F; Yang X; Li Q; Wei Z; Han J; Duan Y; Chen Y
    Cell Signal; 2020 Jan; 65():109429. PubMed ID: 31654717
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models.
    Toppo E; Sylvester Darvin S; Esakkimuthu S; Buvanesvaragurunathan K; Ajeesh Krishna TP; Antony Caesar S; Stalin A; Balakrishna K; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
    Biomed Pharmacother; 2018 Nov; 107():979-988. PubMed ID: 30257410
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Grape skin extract reduces adipogenesis- and lipogenesis-related gene expression in 3T3-L1 adipocytes through the peroxisome proliferator-activated receptor-γ signaling pathway.
    Jeong YS; Hong JH; Cho KH; Jung HK
    Nutr Res; 2012 Jul; 32(7):514-21. PubMed ID: 22901559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation.
    Muhlhausler BS; Morrison JL; McMillen IC
    Endocrinology; 2009 Sep; 150(9):4287-94. PubMed ID: 19520784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
    Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.